+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

Phase 4
Age: 19Years +
All Genders
ID05527717

Comparison of Immediate Multi-Vessel PCI Versus Culprit-Lesion Only PCI in Adults with Acute Myocardial Infarction and Cardiogenic Shock Using Veno-Arterial ECMO

Led by Samsung Medical Center · Updated on 2024-11-06

560

Participants Needed

1

Research Sites

52 weeks

Total Duration

AI-Summary

What This Trial Is About

Researchers are investigating the best revascularization approach for patients with acute myocardial infarction AMI complicated by cardiogenic shock CS who require veno-arterial extracorporeal membrane oxygenator VA-ECMO. This trial compares whether performing immediate multi-vessel percutaneous coronary intervention PCI leads to better clinical outcomes than treating only the culprit lesion in patients with multi-vessel coronary artery disease and advanced CS. The study addresses ongoing uncertainty about the benefits of non-culprit artery treatment in this high-risk patient group. Participants will be randomly assigned to one of two groups one receiving PCI only on the culprit lesion, and the other undergoing immediate PCI on multiple vessels during the primary procedure. Randomization occurs after coronary angiography before or during primary PCI for the infarct-related artery. Both treatment approaches are performed during the primary PCI procedure while patients are supported by VA-ECMO. During the study, participants will be closely monitored for outcomes such as rates of death or advanced heart failure requiring cardiac replacement therapy within 90 days after PCI. Additional assessments include in-hospital mortality, success and timing of VA-ECMO weaning, complications, lengths of ICU stay, and various cardiac events up to 12 months after PCI. Researchers will gather detailed clinical data to evaluate safety and effectiveness, with overall participation lasting at least 90 days following the primary intervention.

CONDITIONS

Brief Title

Revascularization Strategy of Multivessel Disease for Patients with Acute Myocardial Infarction Complicated by Cardiogenic Shock Undergoing Veno-arterial Extracorporeal Membrane Oxygenator

Research Team

J

Jeong Hoon Yang, MD

K

Ki Hong Choi, MD

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here